EUVIMEDOpdag EUVIMED
Vergleichsstudie

Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping

Laura Lewis, Monika Smith, Kristin Boutard, Matthew Fedoruk iD, Geoff Miller iD

Drug Testing and Analysis · 2025-08 · 17 (8) · 1145-1149

DOI: 10.1002/dta.3818 ↗

At a glance

Vergleichsstudie in Drug Testing and Analysis, published online on 2024-10-19. Written by Laura Lewis and 4 co-authors. Institution: United States Anti-Doping Agency, Colorado Springs, Colorado, USA. Major MEDLINE topics: Doping in Sports, Substance Abuse Detection, Blood Specimen Collection. Cited 10 times so far (Crossref); 6 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Blood collection is an important facet of anti‐doping testing, forming the basis of the hematological module of the athlete biological passport (ABP). Presently, whole blood is collected via venepucture under standardized conditions, in accordance with the World Anti‐doping Agency's International Standard for Testing and Investigations (ISTI). Advances in capillary whole blood collection technology now afford the ability to collect microvolumetric capillary whole blood from the upper arm (or other suitable vascular location such as the abdomen) that is “needle‐free” and virtually painless. Previous work has demonstrated the suitability and feasibility of capillary whole blood compared with venous using the Tasso+ device. Recently, other microcapillary devices have received FDA approval increasing the options available to the anti‐doping community. The present study extends previous work, by collecting microliter capillary whole blood samples via two different FDA approved devices (RedDrop and the Tasso+ device) to compare with venous blood collected simultaneously. Ten participants provided three matched blood samples (2× capillary and 1× venous) in accordance with WADA ABP guidelines for blood sample collection, for a total of 30 samples. Capillary samples from both devices showed excellent laboratory agreement with venous blood for all CBC parameters, with the exception of platelets. Excellent laboratory agreement was also observed between the two microcapillary collection devices. Irrespective of the device, microcapillary blood collection provides a valid alternative to venous blood collection for ABP purposes.

Subjects

MeSH terms (MEDLINE)

Doping in SportsSubstance Abuse DetectionBlood Specimen CollectionHumansCapillariesMaleAdultFemale

Author keywords

anti‐dopingbiological passportblood collectioncapillary blood

Authors and institutions

  • United States Anti-Doping Agency, Colorado Springs, Colorado, USA.
  • Sports Medicine Research Testing Laboratory, Salt Lake City, Utah, USA.

ORCID profiles: Matthew Fedoruk, Geoff Miller

Cite

APA

Lewis, L., Smith, M., Boutard, K., Fedoruk, M., & Miller, G. (2025). Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping. Drug Testing and Analysis, 17(8), 1145-1149. https://doi.org/10.1002/dta.3818

Vancouver

Lewis L, Smith M, Boutard K, Fedoruk M, Miller G. Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping. Drug Testing and Analysis. 2025;17(8):1145-1149. doi:10.1002/dta.3818

BibTeX
@article{Lewis2025,
  author = {Lewis, Laura and Smith, Monika and Boutard, Kristin and Fedoruk, Matthew and Miller, Geoff},
  title = {Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping},
  journal = {Drug Testing and Analysis},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {1145--1149},
  doi = {10.1002/dta.3818}
}
Start for free →